Table 1. Relationships between GNRI and clinicopathological features in all patients with ESCC.
| Characteristics | Total patients | GNRI | ||
|---|---|---|---|---|
| < 97.1 (n = 81) | ≥ 97.1 (n = 110) | p value | ||
| Age (years) | 67 (48–84) | 66 (47–85) | 0.3170 | |
| Sex | 0.1267 | |||
| Male | 169 | 75 | 94 | |
| Female | 22 | 6 | 16 | |
| BMI | 18.5 (13.1–26.3) | 22.2 (16.5–31.8) | < 0.0001 | |
| WBC | 5730 (2560–12240) | 5435 (2710–17140) | 0.7366 | |
| Neutrophil | 3425 (849–9420) | 3257 (860–15169) | 0.5700 | |
| Lymphocyte | 1410 (160–3470) | 1600 (380–3340) | 0.0795 | |
| Platelet | 24.4 (8.7–49.5) | 21.6 (11.2–41.8) | 0.0574 | |
| Location of tumor | 0.6629 | |||
| Ce | 13 | 7 | 6 | |
| Ut | 10 | 4 | 6 | |
| Mt | 79 | 36 | 43 | |
| Lt | 69 | 28 | 41 | |
| Ae | 20 | 6 | 14 | |
| Tumor size (mm) | 5.0 (0.2–70.0) | 3.7 (0.5-48.0) | 0.0077 | |
| Depth of tumor | < 0.0001 | |||
| T1a–1b | 81 | 23 | 58 | |
| 2 | 16 | 4 | 12 | |
| 3 | 75 | 39 | 36 | |
| 4a–4b | 19 | 15 | 4 | |
| Lymph node metastasis | 0.0901 | |||
| N0 | 102 | 40 | 62 | |
| N1 | 53 | 28 | 25 | |
| N2 | 21 | 5 | 16 | |
| N3 | 15 | 8 | 7 | |
| Pathological TNM stage | 0.0038 | |||
| Ia–Ib | 73 | 20 | 53 | |
| IIa–IIb | 41 | 20 | 21 | |
| IIIa–IIIc | 77 | 41 | 36 | |
| Operation time (min) | 647 (156–1073) | 653 (196–1258) | 0.8831 | |
| Intraoperative blood loss (ml) | 630 (0–10000) | 375 (0–3000) | 0.0842 | |
| SCC antigen | 1.3 (0.1–20.8) | 0.8 (0.1–6.0) | 0.0001 | |
| Albumin | 3.6 (2.3–4.6) | 4.2 (3.3–4.9) | < 0.0001 | |
| CRP | 0.20 (0.01–6.02) | 0.20 (0.01–4.00) | < 0.0001 | |